会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Polymeric drug delivery system for hydrophobic drugs
    • 用于疏水药物的聚合物药物递送系统
    • US20050249799A1
    • 2005-11-10
    • US11072098
    • 2005-03-03
    • Jules JacobMichael BassettMarcus SchestopolEdith MathlowitzAvinash NangiaBennett CarterPeyman MoslemyZe'ev ShakedDavid EnscoreCourtney Sikes
    • Jules JacobMichael BassettMarcus SchestopolEdith MathlowitzAvinash NangiaBennett CarterPeyman MoslemyZe'ev ShakedDavid EnscoreCourtney Sikes
    • A61K9/00A61K9/14A61K9/16A61K9/20A61K9/24A61K9/28A61K9/48
    • A61K9/209A61K9/0065A61K9/1635A61K9/1641A61K9/1647A61K9/1652A61K9/1676A61K9/2054A61K9/2077A61K9/2086A61K9/2853
    • An oral delivery system for Class II drugs that have low oral bioavailability due to their insolubility in water and slow dissolution kinetics and method for making such a drug delivery system are disclosed herein. The formulation may be a controlled release or immediate release formulation. The immediate release formulation contains a Class II drug, together with a hydrophobic polymer, preferably a bioadhesive polymer. In one embodiment, the drug and polymer are co-dissolved in a common solvent. The solution is formed into small solid particles by any convenient method, particularly by spray drying. The resulting particles contain drug dispersed as small particles in a polymeric matrix. The particles are stable against aggregation, and can be put into capsules or tableted for administration. The controlled release formulations contain a BCS Class II drug and a bioadhesive polymer. The controlled release formulations may be in the form of a tablet, capsules, mini-tab, microparticulate, or osmotic pump. Enhancement of oral uptake of the drug from use of bioadhesive polymers occurs through (1) increased dissolution kinetics due to stable micronization of the drug, (2) rapid release of the drug from the polymer in the GI tract; and (3) prolonged GI transit due to bioadhesive properties of the polymers. The combination of these effects allows the preparation of a compact, stable dosage form suitable for oral administration of many class II drugs.
    • 本文公开了由于其在水中的不溶性和缓慢的溶解动力学以及制备这种药物递送系统的方法而具有低口服生物利用度的II类药物的口服递送系统。 制剂可以是控释或即时释放制剂。 立即释放制剂含有II类药物,以及疏水性聚合物,优选生物粘附性聚合物。 在一个实施方案中,将药物和聚合物共溶于常用溶剂。 通过任何方便的方法,特别是通过喷雾干燥,将溶液形成小的固体颗粒。 所得到的颗粒含有作为小颗粒分散在聚合物基质中的药物。 颗粒对聚集是稳定的,并且可以放入胶囊或压片以供给药。 控释制剂含有BCS II类药物和生物粘附性聚合物。 控制释放制剂可以是片剂,胶囊,迷你片,微粒或渗透泵的形式。 通过(1)由于药物的稳定的微粉化引起的溶出动力学增加,(2)药物从胃肠道中的聚合物快速释放,增加了使用生物粘附性聚合物对药物的口服摄取。 和(3)由于聚合物的生物粘合性质而延长GI运输。 这些作用的组合允许制备适于口服多种II类药物的紧凑,稳定的剂型。
    • 5. 发明申请
    • STENT AND STENT DELIVERY SYSTEM WITH IMPROVED DELIVERABILITY
    • 具有改进的可交付性的STENT和STENT交付系统
    • US20110190864A1
    • 2011-08-04
    • US13014632
    • 2011-01-26
    • James B. McClainDouglas TaylorDavid Enscore
    • James B. McClainDouglas TaylorDavid Enscore
    • A61F2/84A61F2/82
    • A61F2/958A61F2/0077A61F2002/826A61F2250/003
    • Stent delivery systems having improved deliverability comprising an elongate member having an inflation lumen and a guidewire lumen therein; a balloon having an interior that is in fluid communication with the inflation lumen; and a stent comprising a coating mounted on the balloon. Methods for making stent delivery systems having improved deliverability. Methods for delivering two stent delivery systems concurrently through a guiding catheter, each stent delivery system comprising elongate member having an inflation lumen and a guidewire lumen therein, a balloon having an interior that is in fluid communication with the inflation lumen, and a stent comprising a coating mounted on the balloon. Stent coatings may comprise a pharmaceutical agent at least a portion of which is in crystalline form.
    • 具有改善的输送能力的支架输送系统包括具有充气腔和其中的导丝腔的细长构件; 具有与膨胀腔流体连通的内部的气囊; 以及支架,其包括安装在气囊上的涂层。 用于制备具有改善的输送性的支架输送系统的方法。 用于通过引导导管同时递送两个支架输送系统的方法,每个支架输送系统包括具有充气腔和其中的导丝腔的细长构件,具有与充气腔流体连通的内部的球囊,以及支架, 涂层安装在气球上。 支架涂层可以包含至少一部分为结晶形式的药剂。